Medfield Diagnostics
6
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers
Role: collaborator
Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase
Role: collaborator
Mobile Microwave-based Diagnosis and Monitoring of Stroke
Role: collaborator
Detecting Traumatic Intracranial Hemorrhage With Microwave Technology
Role: collaborator
Detecting Chronic Subdural Hematoma With Microwave Technology
Role: collaborator
Study to Evaluate Performance, Usability, Safety of Microwave Technology When Collecting Data From Patients With Stroke
Role: lead
All 6 trials loaded